Arcus Biosciences (NYSE:RCUS) reported its Q3 earnings results on Monday, November 8, 2021 at 04:10 PM.
Here's what investors need to know about the announcement.
Earnings
Arcus Biosciences their estimated earnings by 2.78%, reporting an EPS of $-1.11 versus an estimate of $-1.08, which did not surprise analysts.
Revenue was up $55,069,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.21, which was followed by a 10.56% drop in the share price the next day.
Here's a look at Arcus Biosciences's past performance:
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
